Brought to you by 
Luminex, Zeus to co-develop assays
15 Aug 2000
Executive Summary
Focusing initially in the therapeutic area of autoimmune disease, biological testing company Luminex and Zeus Scientific (diagnostic test systems) will jointly develop clinical diagnostic assay kits using Luminex's LabMAP multi-analyte technology platform. Zeus will commercialize the resulting technology as the AtheNA Multi-Lyte analysis system.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Luminex, Zeus to co-develop assays
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice